Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo
NCT01257906 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1225
Last updated 2010-12-10
Summary
ZIANA® (clindamycin phosphate 1.2% and tretinoin 0.025%) gel, marketed by Medicis, The Dermatology Company®, is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC has developed a generic formulation of clindamycin phosphate (1.2%) and tretinoin (0.025%) topical gel and the current study is designed to evaluate the bioequivalence of this formulation to ZIANA®.
Conditions
- MILD TO SEVERE ACNE VULGARIS
Interventions
- DRUG
-
CLIND PHOSPHATE (1.2%) AND TRETINOIN (0.025%) TOPICAL GEL
Topical Gel applied in the evening for 84 days
- DRUG
-
ZIANA®
Topical Gel applied in the evening for 84 days
- DRUG
-
Vehicle Control
Topical Gel applied in the evening for 84 days.
Sponsors & Collaborators
-
Actavis Mid-Atlantic LLC
lead INDUSTRY
Principal Investigators
-
Madhuri Tadepalli, MD · Skin and Cosmetology Clinic
-
Bela J. Shah, MD · BJ Medical College and Civil Hospital
-
Abir Saraswat, MD · Indu Shree Clinic
-
Manoj K. Parekh, MD · Bhagwan Mahaveer Jain Hospital
-
V. R. Sardesai, MD · Sardesai Clinic
-
Girish BS, MD · Justice KS Hedge Charitable Hospital
-
Leelavathy B., MD · Bowring & Lady Curzon Hospital
-
Rajkumar V., MD · Dhanawantari Polyclinic
-
Mukta Sachdev, MD · MS Clinical Research Pvt. Ltd
-
Anilkumar Malik, MD · G.M Modi Hospital
-
Narayana Rao, MD · Skin and Cosmetology
-
Guru Prasad, MD · Dayal Clinic
-
Jayadev Betkerur, MD · J.S.S. Medical College Hospital
-
Bhanuja Rani, MD · GVK Clinic
-
Mishra RS, MD · Skin Care and Cosmetology Centre
-
Hemanji R. Jerajani, MD · L.T.M. Medical College & General Hospital
-
BV Ramachandra, MD · Andhra Medical College
-
Akhilesh Agarwal, MD · Twacha Skin and Hair Clinic
-
Deepak Kotkar, MD · Dr. Deepak Kotkar Clinic
-
Alur S. Kumar, MD · Owaisi Hospital & Research Centre
-
Jayesh Kothari, MD · Skin Clinic
-
MG Gopal, MD · Kempegowda Institute of Medical Sciences
-
D. N. Balraj, MD · Rajbal Skin Clinic
-
Meethesh Agrawal, MD · Skin Clinic
-
Ravi M. Rathod, MD · Skin Care Centre
-
Ranjan C. Raval, MD · Smt. NHL Medical College and V.S. Hospital
-
V. K. Somani, MD · Somani Skin and Cosmetology Institute
-
Kailash Bhatia, MD · Bhatia Skin, Laser, & Cosmetic Center
-
Bhavesh K. Swarnakar, MD · Swarnakar's Clinic
-
Jayakar Thomas, MD · J.T. Skin Care Centre
-
Karigi Siddalingappa, MD · Vijayanagara Institute Of Medical Sciences
-
DVS Pratap, MD · Durga Bai Deshmukh Hospital and Research Center
-
Amit Madan, MD · Madan's Skin Care Centre
-
Rajeev Agarwal, MD · MV Hospital and Research Center
-
Ramesh Bhat, MD · Father Muller Medical College and Hospital
-
Ravindra B P, MD · Raga's Skin Care
-
S. Sacchidananda, MD · CITI Hospital
-
Veena Patil, MD · Medi Derma Hospital
-
Dinesh V Deshpande, MD · Deshpande Skin Clinic
-
Ajay J Deshpande, MD · Dr. Ajay Deshpande's Clinic
-
Sudhakar Grandhi, MD · Medipoint Hospitals Pvt. Ltd.
-
Anirudh D. Gulanikar, MD · Gulanikar Skin Clinic
-
Prashant K Palwade, MD · Keshav Skin and Hair Clinic
-
Uday Kulkarni, MD · Skin Care and Cosmetology Clinic
-
Amit Luthra, MD · Ishira Skin Clinic
-
K Venkatachalam, MD · Sri Gayathri Skin Care and Hair Transplant Centre
-
Apoorva Jain, MD · Max Skin Care Centre
-
Pradyumna P Vaidya, MD · Clinical Development Centre Pvt. Ltd.
-
Prachi A Matte, MD · Derma Lazer Clinic
-
Vikrant A Saoji, MD · Dr. Vikrant Saoji Skin Clinic
-
Archana M Goyal, MD · Laser and Skin Clinic Jaipur
-
Anshu Jain, MD · Skin Clinic
-
Vijay Zawar, MD · Skin Clinic
-
Sushil Y Pande, MD · Sparsh Hospital and Poly Clinic
-
Sujata Sengupta, MD · BP Poddar Hospital and Medical Research Limited
-
Kote R Purushottam, MD · Skin Care Clinic
-
Kiran Godse, MD · Shree Skin Centre and Pathology Laboratory
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2010-10-31
- Completion
- 2010-10-31
Countries
- India
Study Locations
More Related Trials
-
Efficacy & Safety of Clindamycin and Tretinoin in Acne
NCT01111994 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne
NCT01422785 ·Status: UNKNOWN ·Phase: PHASE4
-
Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications
NCT01015638 ·Status: COMPLETED ·Phase: PHASE4
-
To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris
NCT03427554 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris
NCT01448733 ·Status: UNKNOWN ·Phase: PHASE4
-
To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris
NCT03433378 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash
NCT00891982 ·Status: COMPLETED ·Phase: PHASE3
-
W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers
NCT01915758 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris
NCT04724473 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate
NCT00838812 ·Status: COMPLETED ·Phase: PHASE3
-
W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne
NCT01132443 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Treatment for Moderate to Severe Acne
NCT01206348 ·Status: COMPLETED ·Phase: PHASE4
-
To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.
NCT02465632 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne
NCT00841776 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations
NCT01044264 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris
NCT01182636 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris
NCT03522441 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products
NCT02731105 ·Status: COMPLETED ·Phase: PHASE4
-
W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers
NCT01929278 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne
NCT00713609 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris
NCT01769664 ·Status: COMPLETED ·Phase: PHASE1
-
Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris
NCT02616614 ·Status: COMPLETED ·Phase: PHASE3
-
A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris
NCT02595034 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%
NCT04329403 ·Status: WITHDRAWN ·Phase: PHASE3
-
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel
NCT02005666 ·Status: COMPLETED ·Phase: PHASE3